Comparison of Prognostic Values of Seven Immune Indexes in Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab: How Effective Can They Be Regarding Our Treatment Decisions?

<i>Background and Objectives</i>: In this study, we evaluated the impact of seven immune indexes on treatment response and survival outcomes in advanced non-small-cell lung cancer (NSCLC) patients receiving second-line and subsequent nivolumab treatment under real-life conditions. <i&...

Full description

Saved in:
Bibliographic Details
Main Authors: Arife Ulas, Beyza Temel, Fahriye Tugba Kos
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/60/11/1792
Tags: Add Tag
No Tags, Be the first to tag this record!